Home › Female Infertility › NCT04167748

Preimplantation Genetic Testing in Women of Advanced Maternal Age

GEnetic Testing in Elective Single Embryo Transfer in Women of Advanced Maternal Age

Who can join

Ages 35 to 40 · Women

Inclusion Criteria:

* Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
* Utilization of Intracytoplasmic Sperm Injection ICSI
* Utilization of ejaculated or testicular sperm
* Utilization of autologous or donor sperm
* All Controlled Ovarian Hyperstimulation (COH) protocols

Exclusion criteria:

* Patients with anovulatory Polycystic ovarian syndrome (PCOS)
* Utilization of donor oocytes
* Utilization of gestational carrier
* Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages
* Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers

About the study

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

What is being tested

• Preimplantation genetic testing for aneuploidy (PGT-A) (procedure)

Sponsor: Genomic Prediction Inc. · Participants: 240 · Started: Mar 5, 2021

Contact the study team

• Nathan R Treff, PhD · Phone: (973) 529-4223
• Diego Marin, PhD · Phone: (973) 529-4223

Official record on ClinicalTrials.gov — NCT04167748

Locations in the U.S.

Conditions

• Female Infertility

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.